169 related articles for article (PubMed ID: 2038014)
1. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal.
Fries JF
J Rheumatol Suppl; 1991 Mar; 28():6-10. PubMed ID: 2038014
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and NSAID induced gastropathy.
Zeidler H
J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
[TBL] [Abstract][Full Text] [Related]
3. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
[TBL] [Abstract][Full Text] [Related]
4. Identification of patients at risk for gastropathy associated with NSAID use.
Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
J Rheumatol Suppl; 1990 Feb; 20():12-9. PubMed ID: 2325051
[TBL] [Abstract][Full Text] [Related]
5. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
Wolfe F; Hawley DJ
J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
[TBL] [Abstract][Full Text] [Related]
6. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
7. NSAID gastropathy. A new understanding.
Roth SH
Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
[TBL] [Abstract][Full Text] [Related]
8. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
9. Assessing and understanding patient risk.
Fries JF
Scand J Rheumatol Suppl; 1992; 92():21-4. PubMed ID: 1574684
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis and treatment of NSAID-induced gastropathy.
Ament PW; Childers RS
Am Fam Physician; 1997 Mar; 55(4):1323-6, 1331-2. PubMed ID: 9092293
[TBL] [Abstract][Full Text] [Related]
11. Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis.
Keenan GF; Giannini EH; Athreya BH
J Rheumatol; 1995 Jun; 22(6):1149-51. PubMed ID: 7674245
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
[TBL] [Abstract][Full Text] [Related]
13. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
Goldstein JL; Larson LR; Yamashita BD
Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
[TBL] [Abstract][Full Text] [Related]
14. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
15. Predicting the risk of gastrointestinal bleeding due to nonsteroidal antiinflammatory drugs: NSAID electronic assessment of risk.
Cheetham TC; Levy G; Spence M
J Rheumatol; 2003 Oct; 30(10):2241-4. PubMed ID: 14528523
[TBL] [Abstract][Full Text] [Related]
16. There's the forest. The object lesson of NSAID "gastropathy".
Hadler NM
J Rheumatol; 1990 Mar; 17(3):280-2. PubMed ID: 2110251
[No Abstract] [Full Text] [Related]
17. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
Cibere J; Sibley JT; Haga M
J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
[TBL] [Abstract][Full Text] [Related]
18. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.
Singh G
Am J Med; 1998 Jul; 105(1B):31S-38S. PubMed ID: 9715832
[TBL] [Abstract][Full Text] [Related]
19. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
Fries JF; Bruce B
J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
[TBL] [Abstract][Full Text] [Related]
20. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
